SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Godavari Drugs - Quaterly Results

14 Feb 2023 Evaluate
The Revenue for the quarter ended  December 2022 of Rs. 391.58 millions grew by 16.00 % from Rs. 337.57 millions.A big decline of -49.70% was reported for the quarter ended December 2022 to Rs. 6.70  millions from Rs. 13.32 millions of corresponding previous quarter.Operating Profit reported a sharp decline to 25.68 millions from 26.38 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 391.58 337.57 16.00 1222.55 1168.25 4.65 1611.06 1226.70 31.33
Other Income 2.99 0.53 464.15 4.98 1.61 209.32 2.76 4.10 -32.68
PBIDT 25.68 26.38 -2.65 77.35 87.44 -11.54 115.66 102.50 12.84
Interest 10.99 7.33 49.93 28.98 22.31 29.90 28.49 33.21 -14.21
PBDT 14.69 19.05 -22.89 48.37 65.13 -25.73 87.17 69.29 25.80
Depreciation 5.14 4.34 18.43 14.47 12.77 13.31 16.96 12.23 38.68
PBT 9.55 14.71 -35.08 33.90 52.36 -35.26 70.21 57.06 23.05
TAX 2.85 1.39 105.04 9.35 12.60 -25.79 17.75 15.78 12.48
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 6.70 13.32 -49.70 24.55 39.76 -38.25 52.46 41.28 27.08
Equity 75.31 75.31 0.00 75.31 75.31 0.00 75.31 75.31 0.00
PBIDTM(%) 6.56 7.81 -16.08 6.33 7.48 -15.47 7.18 8.36 -14.08

Godavari Drugs Share Price

130.15 4.05 (3.21%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×